Covid-19: The Moderna Vaccine Enters the Final Phase of Clinical Trials

30,000 people are participating in Phase 3 of this COVID-19 clinical trial, which is being conducted by the biotech company Moderna. After the previous phases, the vaccine has generated a high level of antibodies in the participants. Vaccines The race for the vaccine is accelerating. Since the beginning of the COVID-19 epidemic, scientists around the world have been working to develop an effective vaccine to stop this global pandemic. On Tuesday, July 14, Moderna an American biotechnology company announced that it will enter the final phase of clinical trials for a Covid-19 vaccine on July 27. Related:┬áThe BCG a Tuberculosis … Continue reading Covid-19: The Moderna Vaccine Enters the Final Phase of Clinical Trials